MACROPHAGE ACTIVATION SYNDROME
Clinical trials for MACROPHAGE ACTIVATION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MACROPHAGE ACTIVATION SYNDROME trials appear
Sign up with your email to follow new studies for MACROPHAGE ACTIVATION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets deadly immune storm in rare inflammatory diseases
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with a life-threatening immune overreaction (macrophage activation syndrome) linked to Still's disease or lupus. The goal was to see if the drug could safely calm the immune system and improve blood markers and …
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Scientists uncover clues to deadly sepsis complication
Knowledge-focused CompletedThis study looked at 27 adults in intensive care to understand the inflammation behind macrophage activation syndrome (MAS) triggered by bacterial sepsis. MAS is a serious condition with a high death rate, and current treatments are not well-defined. By measuring specific inflamm…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC